Novartis’ FCPA Settlement and New Compliance Guidance

11
In late June, the DOJ and SEC announced that pharma company Novartis AG and its former subsidiary Alcon Pte Ltd had agreed to pay a combined $347 million to resolve allegations that they engaged in conspiracies to bribe public hospitals and clinics in Greece, Vietnam, and South Korea, much of it to increase prescriptions and […]
Must be a Paid Member or a Free Trial Member to Access Content. Members log in here.